Pathology Devices Market

Pathology devices sales will rise through 2036, driven by immunoassays technology at 17.2% of the technology segment in 2026, supported by steady procurement volumes and standardization across manufacturing applications. The market was valued at USD 6.60 billion in 2025 and is expected to be worth USD 12.66 billion by 2036.